Pharmacology of the lower urinary tract

Pharmacology of the lower urinary tract provides the basis for medical treatment of lower urinary tract symptoms (LUTS). Therapy of LUTS addresses obstructive symptoms (frequently explained by increased prostate smooth muscle tone and prostate enlargement) in patients with benign prostate hyperplasi...

Full description

Bibliographic Details
Published in:	Indian Journal of Urology
Main Authors:	Martin Hennenberg, Christian G Stief, Christian Gratzke
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-01-01
Subjects:	Alpha1 adrenoreceptor arginine vasopressors endocannabinoids 5 alpha reductase muscarinic receptors phosphodiesterase vitamin D
Online Access:	http://www.indianjurol.com/article.asp?issn=0970-1591;year=2014;volume=30;issue=2;spage=181;epage=188;aulast=Hennenberg

Similar Items

Adreno-Muscarinic Synergy of Contractile Responses From Human Hyperplastic Prostate
by: Ben T. Blake-James, et al.
Published: (2024-02-01)

Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms
by: Yeon Joo Kim, et al.
Published: (2020-09-01)

A comparison of detomidine in combination with saline, morphine or methadone in horses submitted to experimental oral stimuli
by: Rafael Costa Guilhen, et al.
Published: (2015-12-01)

A comparison of detomidine in combination with saline, morphine or methadone in horses submitted to experimental oral stimuli
by: Rafael Costa Guilhen, et al.
Published: (2015-12-01)

Tadalafil vs Tamsulosin for the Management of Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: A Randomised Clinical Trial
by: A Venkata Ranga Swamy, et al.
Published: (2023-09-01)

Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
by: Dong Hyuk Kang, et al.
Published: (2011-12-01)

THE GENE OF ALPHA2A-ADRENORECEPTOR AND ESSENTIAL ARTERIAL HYPERTENSION
by: T. A. Bairova, et al.
Published: (2014-11-01)

Acetylcholine, Another Factor in Breast Cancer
by: Juan P. Muñoz, et al.
Published: (2023-11-01)

The Relationship between Muscarinic and Cannabinoid Receptors in Neuronal Excitability and Epilepsy: A Review
by: Ryan Renaldo Hall, et al.
Published: (2024-05-01)

Risk of poor glycemic control in tamsulosin versus finasteride users with type 2 diabetes mellitus
by: Minh-Ha Nguyen, et al.
Published: (2025-02-01)

Symptomatic benign prostatic hyperplasia: the role of 5-alpha-reductase inhibitors in the prevention of acute urinary retention and surgical therapy
by: Norma Marigliano, et al.
Published: (2012-01-01)

Atipamezole Reverses Cardiovascular Changes Induced by High-Dose Medetomidine in Cats Undergoing Sedation for Semen Collection
by: Anna-Lea R. Diggelmann, et al.
Published: (2023-06-01)

Adrenergic mechanisms of absence status epilepticus
by: Evgenia Sitnikova
Published: (2023-11-01)

Expression of <i>CSF1</i>, <i>AR</i>, and <i>SRD5A2</i> during Postnatal Development of the Boar Reproductive Tract
by: Kimberley Katleba, et al.
Published: (2022-08-01)

Evaluation of capillary leakage after vasopressin resuscitation in a hemorrhagic shock model
by: Roberto Bini, et al.
Published: (2018-03-01)

Improvement in Near Vision Following Silodosin Treatment in Patients With Lower Urinary Tract Symptoms
by: Hyun Jin Shin, et al.
Published: (2021-06-01)

Evaluation of apoptosis indexes in currently used oral alpha-blockers in prostate: a pilot study
by: Mehmet Demir, et al.

Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies
by: Massimiliano Creta, et al.
Published: (2021-02-01)

Non‑Hormonal treatment of BPH/BOO
by: Nadir I Osman, et al.
Published: (2014-01-01)

Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
by: Mariana Escamilla-Cruz, et al.
Published: (2023-07-01)

Genetic and other epidemiological risk factors of infants and children with hypospadias: a case control study
by: Wafaa Moustafa, et al.
Published: (2023-10-01)

A role for steroid 5 alpha-reductase 1 in vascular remodeling during endometrial decidualization
by: Isaac W. Shaw, et al.
Published: (2022-11-01)

5‐Alpha reductase deficiency; an important cause of 46, XY DSD: Report of three cases within a family
by: Samaneh Noroozi Asl, et al.
Published: (2023-05-01)

Co-Relation Between Androgenetic Alopecia and Severity of COVID-19 Disease - A Cross-Sectional Study
by: Muhammad Waseem Shahid, et al.
Published: (2022-12-01)

5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
by: Ziting Wang, et al.
Published: (2023-04-01)

Effects of red ginseng oil(KGC11o) on testosterone-propionate-induced benign prostatic hyperplasia
by: Jeong Yoon Lee, et al.
Published: (2022-05-01)

Expression of catecholaminergic genes in the midbrain and prepulse inhibition in rats with a genetic catatonia
by: M. A. Ryazanova, et al.
Published: (2017-12-01)

Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
by: Antonio La Torre, et al.
Published: (2021-07-01)

The Use of 5-Alpha Reductase Inhibitors Improves the Detection of Prostate Cancer by Increasing Opportunities for Repeated Prostate-Specific Antigen Testing: A Decade-Long (2007–2016) Nationwide Observational Study in Korea
by: Young Hwii Ko, et al.
Published: (2023-03-01)

Do statins decrease testosterone in men? Systematic review and meta-analysis
by: Felipe Placco Araujo Glina, et al.
Published: (2024-04-01)

The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational Study
by: Jong Hyun Pyun, et al.
Published: (2024-04-01)

Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays
by: Lilian Mussi, et al.
Published: (2021-11-01)

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia
by: Kang Jun Cho, et al.
Published: (2011-09-01)

Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
by: Jae Heon Kim, et al.
Published: (2020-10-01)

Effects of Endotoxemia and Blood Pressure on Microcirculation and Noradrenaline Needs With or Without Dexmedetomidine in Beagle Dogs—A Blinded Cross-Over Study
by: Barbara Steblaj, et al.
Published: (2025-06-01)

Hormonal manipulation of lower urinary tract symptoms secondary to benign prostatic obstruction
by: Adita Raja, et al.
Published: (2014-01-01)

The Endocannabinoid System across Postnatal Development in Transmembrane Domain Neuregulin 1 Mutant Mice
by: Rose Chesworth, et al.
Published: (2018-02-01)

Is Early Surgical Treatment for Benign Prostatic Hyperplasia Preferable to Prolonged Medical Therapy: Pros and Cons
by: Cora Fogaing, et al.
Published: (2021-04-01)

Biological activity produced by ruthenium chloride on perfusion pressure, left ventricular pressure and heart failure using an isolated rat heart model
by: Figueroa-Valverde Lauro, et al.
Published: (2024-07-01)

Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia
by: Daisuke Gotoh, et al.
Published: (2022-09-01)